299 related articles for article (PubMed ID: 25818077)
1. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
[TBL] [Abstract][Full Text] [Related]
2. Comparing American Gastroenterological Association Pancreatic Cyst Management Guidelines with Fukuoka Consensus Guidelines as Predictors of Advanced Neoplasia in Patients with Suspected Pancreatic Cystic Neoplasms.
Ma GK; Goldberg DS; Thiruvengadam N; Chandrasekhara V; Kochman ML; Ginsberg GG; Vollmer CM; Ahmad NA
J Am Coll Surg; 2016 Nov; 223(5):729-737.e1. PubMed ID: 27497827
[TBL] [Abstract][Full Text] [Related]
3. Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
Sighinolfi M; Quan SY; Lee Y; Ibaseta A; Pham K; Dua MM; Poultsides GA; Visser BC; Norton JA; Park WG
Dig Dis Sci; 2017 Mar; 62(3):626-632. PubMed ID: 28116593
[TBL] [Abstract][Full Text] [Related]
4. Validation of Sendai and Fukuoka consensus guidelines in predicting malignancy in patients with preoperatively diagnosed mucinous pancreatic cystic neoplasms.
Zhou W; Xu Y; Rong Y; Wu W; Kuang T; Xin B; Zhu H; Lou W; Wang D
J Surg Oncol; 2018 Mar; 117(3):409-416. PubMed ID: 29044541
[TBL] [Abstract][Full Text] [Related]
5. Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients.
Goh BK; Tan DM; Thng CH; Lee SY; Low AS; Chan CY; Wong JS; Lee VT; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
Ann Surg Oncol; 2014 Jun; 21(6):1919-26. PubMed ID: 24504924
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Sendai and 2012 International Consensus Guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients.
Goh BK; Thng CH; Tan DM; Low AS; Wong JS; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
Am J Surg; 2014 Aug; 208(2):202-9. PubMed ID: 24530043
[TBL] [Abstract][Full Text] [Related]
7. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients.
Park RHS; Lim GRS; Wu JJY; Koh YX; Teo JY; Cheow PC; Chan CY; Ooi LLPJ; Chung AYF; Goh BKP
Eur J Surg Oncol; 2020 Nov; 46(11):2114-2121. PubMed ID: 32828582
[TBL] [Abstract][Full Text] [Related]
8. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
[TBL] [Abstract][Full Text] [Related]
9. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.
Sawhney MS; Al-Bashir S; Cury MS; Brown A; Chuttani R; Pleskow DK; Callery MP; Vollmer CM
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1373-6. PubMed ID: 19577006
[TBL] [Abstract][Full Text] [Related]
10. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy.
Heckler M; Michalski CW; Schaefle S; Kaiser J; Büchler MW; Hackert T
Pancreatology; 2017; 17(2):255-262. PubMed ID: 28189431
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cyst size and tumor markers in the management of pancreatic cysts: support for the original Sendai criteria.
Hoffman RL; Gates JL; Kochman ML; Ginsberg GG; Ahmad NA; Chandrasekhara V; Furth EE; Vollmer CM; Drebin JA
J Am Coll Surg; 2015 Jun; 220(6):1087-95. PubMed ID: 25868415
[TBL] [Abstract][Full Text] [Related]
12. Utility of the 2006 Sendai and 2012 Fukuoka guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas: A single-center experience with 138 surgically treated patients.
Hsiao CY; Yang CY; Wu JM; Kuo TC; Tien YW
Medicine (Baltimore); 2016 Sep; 95(38):e4922. PubMed ID: 27661043
[TBL] [Abstract][Full Text] [Related]
13. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms.
Xu MM; Yin S; Siddiqui AA; Salem RR; Schrope B; Sethi A; Poneros JM; Gress FG; Genkinger JM; Do C; Brooks CA; Chabot JA; Kluger MD; Kowalski T; Loren DE; Aslanian H; Farrell JJ; Gonda TA
Medicine (Baltimore); 2017 Sep; 96(35):e7900. PubMed ID: 28858107
[TBL] [Abstract][Full Text] [Related]
15. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
Smith AL; Abdul-Karim FW; Goyal A
Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
[TBL] [Abstract][Full Text] [Related]
16. Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?
Goh BK; Tan DM; Chan CY; Lee SY; Lee VT; Thng CH; Low AS; Tai DW; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2015 Sep; 112(4):366-71. PubMed ID: 26280242
[TBL] [Abstract][Full Text] [Related]
17. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
[TBL] [Abstract][Full Text] [Related]
18. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancy in pancreatic cysts with cytology of high-grade epithelial atypia.
Hoda RS; Lu R; Arpin RN; Rosenbaum MW; Pitman MB
Cancer Cytopathol; 2018 Sep; 126(9):773-781. PubMed ID: 30257067
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
Raman SP; Kawamoto S; Blackford A; Hruban RH; Lennon AM; Wolfgang CL; Rezaee N; Edil B; Fishman EK
AJR Am J Roentgenol; 2013 Mar; 200(3):563-9. PubMed ID: 23436845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
